Growing weapons to fight hemophilia

Very few rare diseases have witnessed the gigantic progress in patient care that took place for the hemophilias in the last 20 years. The first landmark was in the 1990s, when recombinant DNA technology afforded the industrial production, regulatory approval and commercialization of an array of fac...

Full description

Bibliographic Details
Main Author: Pier Mannuccio Mannucci
Format: Article
Language:English
Published: PAGEPress Publications 2023-02-01
Series:Bleeding, Thrombosis and Vascular Biology
Subjects:
Online Access:https://btvb.org/btvb/article/view/64